DOBMEIER ERIC 4
4 · Janux Therapeutics, Inc. · Filed Jul 22, 2024
Insider Transaction Report
Form 4
DOBMEIER ERIC
Director
Transactions
- Award
Common Stock
2024-07-19+5,000→ 5,000 total - Award
Stock Option (Right to Buy)
2024-07-19+8,350→ 8,350 totalExercise: $44.68Exp: 2034-07-18→ Common Stock (8,350 underlying) - Award
Common Stock
2024-07-19+2,500→ 7,500 total - Award
Stock Option (Right to Buy)
2024-07-19+16,700→ 16,700 totalExercise: $44.68Exp: 2034-07-18→ Common Stock (16,700 underlying)
Footnotes (4)
- [F1]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in thirty-six equal monthly installments over a three year period, subject to the Reporting Person's continuous service on each such date.
- [F2]Represents the grant of RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on July 19, 2025, subject to the Reporting Person's continuous service on such date.
- [F3]The shares subject to the option will vest in thirty-six equal monthly installments over three years, subject to the Reporting Person's continuous service on each such date.
- [F4]The shares subject to the option will vest in twelve equal monthly installments over one year, subject to the Reporting Person's continuous service on each such date.